The novel dehydroepiandrosterone (DHEA) derivative BNN27 counteracts cognitive deficits induced by the D1/D2 dopaminergic receptor agonist apomorphine in rats

[1] Antoniou K(1991)A comparative study of the behavioral effects of d-amphetamine and apomorphine in the rat Pharmacol Biochem Behav 39 61-70

[2] Kafetzopoulos LE(2018)Apomorphine effects on hippocampus Neural Regen Res 13 2064-2066

[3] Arroyo-Garcia A(2006)Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade Neuropsychopharmacology 31 1900-1909

[4] Rodriguez-Moreno G(2016)Pharmacological properties of microneurotrophin drugs developed for the treatment of amyotrophic lateral sclerosis Biochem Pharmacol 117 68-77

[5] Flores A(2011)Oxidative stress in schizophrenia: an integrated approach Neurosci Biobehav Rev 35 878-893

[6] Auclair MS(1996)Neurotrophins stimulate the release of dopamine from rat mesencephalic neurons via Trk and p75NTR receptors J Biol Chem 271 21100-21107

[7] Kleven J(2017)BNN-20, a synthetic microneurotrophin, strongly protects dopaminergic neurons in the “weaver” mouse, a genetic model of dopamine-denervation, acting through the TrkB neurotrophin receptor Neuropharmacology 121 140-157

[8] Besnard R(2010)Effects of the nitric oxide synthase inhibitor L-NAME on recognition and spatial memory deficits produced by different NMDA receptor antagonists in the rat Neuropsychopharmacology 35 2357-2366

[9] Depoortere A(2009)Novel dehydroepiandrosterone derivatives with antiapopototic activity J Med Chem 52 6569-6587

[10] Newman-Tancredi JP(1993)Spatial but not object recognition is impaired by aging in rats Physiol Behav 53 527-530

[1] Antoniou K(1991)A comparative study of the behavioral effects of d-amphetamine and apomorphine in the rat Pharmacol Biochem Behav 39 61-70

[2] Kafetzopoulos LE(2018)Apomorphine effects on hippocampus Neural Regen Res 13 2064-2066

[3] Arroyo-Garcia A(2006)Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade Neuropsychopharmacology 31 1900-1909

[4] Rodriguez-Moreno G(2016)Pharmacological properties of microneurotrophin drugs developed for the treatment of amyotrophic lateral sclerosis Biochem Pharmacol 117 68-77

[5] Flores A(2011)Oxidative stress in schizophrenia: an integrated approach Neurosci Biobehav Rev 35 878-893

[6] Auclair MS(1996)Neurotrophins stimulate the release of dopamine from rat mesencephalic neurons via Trk and p75NTR receptors J Biol Chem 271 21100-21107

[7] Kleven J(2017)BNN-20, a synthetic microneurotrophin, strongly protects dopaminergic neurons in the “weaver” mouse, a genetic model of dopamine-denervation, acting through the TrkB neurotrophin receptor Neuropharmacology 121 140-157

[8] Besnard R(2010)Effects of the nitric oxide synthase inhibitor L-NAME on recognition and spatial memory deficits produced by different NMDA receptor antagonists in the rat Neuropsychopharmacology 35 2357-2366

[9] Depoortere A(2009)Novel dehydroepiandrosterone derivatives with antiapopototic activity J Med Chem 52 6569-6587

[10] Newman-Tancredi JP(1993)Spatial but not object recognition is impaired by aging in rats Physiol Behav 53 527-530